Skip to main content
Supplement ScienceSupplementScience
meta analysis4,155 participants

N-Acetylcysteine (NAC) for COPD Exacerbations: What the Meta-Analysis Shows

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

A 2015 meta-analysis (around 4,155 chronic bronchitis/COPD patients) found N-acetylcysteine (NAC) was associated with...

A 2015 meta-analysis (around 4,155 chronic bronchitis/COPD patients) found N-acetylcysteine (NAC) was associated with fewer exacerbations, particularly at higher doses (≥1,200 mg/day) over longer use. More recent analyses are mixed, and COPD is a serious medical condition — so NAC should only be considered as an adjunct under the guidance of a clinician, not as a self-directed treatment.

Key Findings

  • A meta-analysis of chronic bronchitis/COPD trials (about 4,155 patients) found N-acetylcysteine was associated with a reduced rate of exacerbations versus control.
  • Benefit was more apparent at higher doses (≥1,200 mg/day in COPD) and with longer-term use.
  • More recent meta-analyses have been mixed, with some finding no significant difference on certain primary outcomes — so the effect is not firmly established.
  • NAC acts as a mucolytic and antioxidant; it is a regulated medicine in some countries rather than a supplement.

Study Details

Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Cazzola M, Calzetta L, Page C, Jardim J, Chuchalin AG, Rogliani P, Matera MG — European Respiratory Review (2015)
NAC was associated with a reduced rate of chronic bronchitis/COPD exacerbations, with greater benefit at higher doses (≥1,200 mg/day) used long-term.
4,155 participantsModerate

Practical Takeaway

N-acetylcysteine (NAC) has been studied as an adjunct for reducing COPD exacerbations, with a meta-analysis associating it with fewer exacerbations, especially at higher doses used long-term. The evidence is mixed across more recent reviews, and COPD is a serious condition that requires proper medical management — NAC is not a substitute for prescribed inhalers, other therapies, or smoking cessation. In some countries NAC is a prescription medicine. Anyone with COPD should discuss NAC with their clinician or pulmonologist before using it, including dose and how it fits their overall care.

Summary

A meta-analysis found N-acetylcysteine was associated with fewer COPD exacerbations, especially at higher doses — though more recent evidence is mixed and NAC should be used under medical care.

Related Supplements

NAC (N-Acetyl Cysteine)

Related Conditions

Liver HealthRespiratory HealthMood SupportImmune Function

Product Reviews

Best NAC Supplements
See our ranked picks →

Learn More

Ergothioneine Benefits: A Mushroom Antioxidant for Healthy Aging?

Frequently Asked Questions

Does NAC reduce COPD flare-ups?

A meta-analysis associated N-acetylcysteine with fewer COPD/chronic bronchitis exacerbations, especially at higher doses used long-term. However, more recent analyses are mixed, so the benefit is not firmly established and should be weighed with a clinician.

How much NAC was studied for COPD?

Benefit was more apparent at higher doses — around 1,200 mg/day or more in COPD — used over the longer term. Because NAC is a medicine in some countries and COPD needs careful management, dose should be decided with a clinician.

Can NAC replace my COPD inhalers or treatment?

No. NAC is studied as an adjunct, not a replacement for prescribed COPD treatments, oxygen, or smoking cessation. COPD is a serious condition that requires proper medical management.

Is NAC safe?

Oral NAC is generally well tolerated, with mainly mild gastrointestinal effects. Still, it can interact with some medications and is prescription-only in some regions, so check with your clinician or pulmonologist before using it for COPD.

Continue Reading

Supplement Guide

NAC (N-Acetyl Cysteine)

Bottom line: NAC 600-1,200 mg/day is the cheapest way to boost glutathione — versatile benefits for liver, lungs, brain, and antioxidant defense.

Product Comparison

Best NAC Supplements

See our ranked picks

Condition Guide

Liver Health

References

  1. Cazzola M, Calzetta L, Page C, Jardim J, Chuchalin AG, Rogliani P, Matera MG (2015). Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis. European Respiratory Review. DOI PubMed